- Home
- BTAI vs CULP Comparison
BTAI vs CULP Comparison
Compare BTAI & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- CULP
- Stock Information
- Founded
- BTAI 2017
- CULP 1972
- Country
- BTAI United States
- CULP United States
- Employees
- BTAI N/A
- CULP N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- CULP Textiles
- Sector
- BTAI Health Care
- CULP Consumer Discretionary
- Exchange
- BTAI Nasdaq
- CULP Nasdaq
- Market Cap
- BTAI 48.3M
- CULP 52.7M
- IPO Year
- BTAI 2018
- CULP N/A
- Fundamental
- Price
- BTAI $2.07
- CULP $4.24
- Analyst Decision
- BTAI Buy
- CULP
- Analyst Count
- BTAI 5
- CULP 0
- Target Price
- BTAI $32.80
- CULP N/A
- AVG Volume (30 Days)
- BTAI 1.0M
- CULP 11.3K
- Earning Date
- BTAI 11-13-2025
- CULP 12-03-2025
- Dividend Yield
- BTAI N/A
- CULP N/A
- EPS Growth
- BTAI N/A
- CULP N/A
- EPS
- BTAI N/A
- CULP N/A
- Revenue
- BTAI $868,000.00
- CULP $207,391,000.00
- Revenue This Year
- BTAI N/A
- CULP $1.93
- Revenue Next Year
- BTAI $614.78
- CULP $2.77
- P/E Ratio
- BTAI N/A
- CULP N/A
- Revenue Growth
- BTAI N/A
- CULP N/A
- 52 Week Low
- BTAI $1.17
- CULP $3.42
- 52 Week High
- BTAI $13.28
- CULP $5.94
- Technical
- Relative Strength Index (RSI)
- BTAI 34.40
- CULP 49.82
- Support Level
- BTAI $2.14
- CULP $4.16
- Resistance Level
- BTAI $2.46
- CULP $4.44
- Average True Range (ATR)
- BTAI 0.17
- CULP 0.10
- MACD
- BTAI 0.00
- CULP -0.00
- Stochastic Oscillator
- BTAI 2.64
- CULP 44.73
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.